• 1
    International Agency for Research on Cancer Monograph on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol. 64. Lyon: IARC, 1995.
  • 2
    Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001; 20: 787487.
  • 3
    Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001; 20: 788898.
  • 4
    Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 51827.
  • 5
    Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76: 1888901.
  • 6
    Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 34250.
  • 7
    Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 177283.
  • 8
    Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 112531.
  • 9
    Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 6757.
  • 10
    Badaracco G, Venuti A, Morello R, Muller A, Marcante ML. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationships with clinical/pathological parameters. Anticancer Res 2000; 20: 13015.
  • 11
    Ferris RL, Martinez I, Sirianni N, Wang J, Lopez-Albaitero A, Gollin SM, Johnson JT, Khan S. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer 2005; 41: 80715.
  • 12
    van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001; 93: 2325.
  • 13
    Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004; 96: 9981006.
  • 14
    Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31: 25966.
  • 15
    Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998; 152: 14556.
  • 16
    Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32: S59S66.
  • 17
    Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, Walboomers JM. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992; 51: 84550.
  • 18
    Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, Lundberg B, Dalianis T, Munck-Wikland E. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004; 112: 101519.
  • 19
    Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002; 102: 1528.
  • 20
    Ragin CC, Reshmi SC, Gollin SM. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 2004; 110: 7019.
  • 21
    Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 621.
  • 22
    Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005; 15: 4905.
  • 23
    Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005; 74: 481514.
  • 24
    Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LSH, Li BFL, Bernard HU. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 2004; 324: 48392.
  • 25
    Badal V, Chuang LSH, Badal S, Tang E, Villa LL, Wheeler CM, Li BFL, Bernard HU. CpG methylation of human papillomavirus-16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 2003; 77: 622734.
  • 26
    Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Barrera- Saldana HA, Wiley DJ, Bernard HU. Conserved methylation patterns of human papillomavirus-16 DNA in asymptomatic infection and cervical neoplasia. J Virol 2004; 78: 1276272.
  • 27
    Turan T, Kalantari M, Calleja-Macias IE, Villa LL, Cubie HA, Cuschieri K, Skomedal H, Barrera-Saldana HA, Bernard HU. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 2006; 349: 17583.
  • 28
    Wiley DJ, Huh J, Chang C, Kalantari M, Rao JY, Goetz M, Msongsong E, Poulter M, Bernard HU. Methylation of human papillomavirus DNA in samples of HIV-1 infected men screened for anal cancer. J Acquir Immune Defic Syndr 2005; 39: 14351.
  • 29
    Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Bauer HM, Peyton C, Wheeler CM. Assessment of known and novel human papillomaviruses by polymerase chain reaction, restriction digest, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 107785.
  • 30
    Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992; 89: 182731.
  • 31
    Myers G, Bernard HU, Delius H, Favre M, Iconogle J, van Ranst M, Wheeler C, eds. Human papillomaviruses 1994 Compendium. Los Alamos, New Mexico, USA: Los Alamos National Laboratory, pp. 1-C-4 to 1-A-7, 1994.
  • 32
    Bernard HU. Gene expression of genital human papillomaviruses and potential antiviral approaches. Antivir Ther 2002; 7: 21937.
  • 33
    Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, Meijer CL, Snijders PJ, Chatis P, Broker TR, Moen PT,Jr, Chow LT. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 2004; 78: 1117286.
  • 34
    Bhattacharjee B, Sengupta S. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 2006; 354: 2805.
  • 35
    Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 2003; 77: 124509.
  • 36
    Doerfler W, Remus R, Muller K, Heller H, Hohlweg U, Schubbert R. The fate of foreign DNA in mammalian cells and organisms. Dev Biol 2001; 106: 8997.
  • 37
    Thain A, Jenkins O, Clarke AR, Gaston K. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 1996; 70: 72335.
  • 38
    Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006; 44: 175562.
  • 39
    Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, Bernard HU. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology, epub ( 2006).
  • 40
    American Joint Committee on Cancer. AJCC Cancer staging manual, 5th Edition. Chicago: Lippincott Williams and Wilkins, 1997.